Eton Pharmaceuticals, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDEton Pharmaceuticals, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 95), indicating clear outperformance against the broad market. Earnings growth of 185% provides fundamental context to the price action. However, price is extended 20% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $31.39 | +13.74% | ABOVE |
| 50 SMA | $29.70 | +20.22% | ABOVE |
| 100 SMA | $24.85 | +43.65% | ABOVE |
| 150 SMA | $21.91 | +62.94% | ABOVE |
| 200 SMA | $21.12 | +69.02% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ETON in an uptrend right now?
ETON has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ETON is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is ETON overbought or oversold?
ETON's RSI (14) is 68. The stock is in neutral territory, neither overbought nor oversold.
Is ETON outperforming the market?
ETON has a Relative Strength (RS) Rating of 95 out of 99. Yes, ETON is a market leader, outperforming 95% of all stocks over the past 12 months.
Where is ETON in its 52-week range?
ETON is trading at $35.70, which is 99% of its 52-week high ($35.99) and 99% above its 52-week low ($13.51).
How volatile is ETON?
ETON has a Beta of 0.44 and 52-week volatility of 54%. It's less volatile than the S&P 500 - generally more stable.